ACX

📍 London and San Francisco, United Kingdom👥 4 employees💰 Last funded Sep 2024
Biotechnology Research🌐 acxtherapeutics.com
Website LinkedIn
ACX is the only company that has successfully reproduced the compounds that bacteria use to kill microbes for therapeutic development. Our patentable technology, which comprises synthetic compounds that mimic natural substances, has applications in humans, animals, and crops. We are beginning with the elimination of crop pathogens—harmful to pests but beneficial for humans!
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Greece
1
Frequently asked questions
Who invested in ACX?
ACX has 1 investors on record on gritt.io.
When did ACX last raise funding?
The most recent investment in ACX recorded on gritt.io was in September 2024.
What industry is ACX in?
ACX operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is ACX based?
ACX is headquartered in London and San Francisco, United Kingdom.